Nurix Therapeutics(NRIX)
$16.33+0.45 (+2.83%)
NRIX
Nurix Therapeutics earnings date
$16.33
At close:+0.45 (+2.83%)
Want to see NRIX full AI Analyst Report?
Nurix Therapeutics (NRIX) Q2 2021 Earnings Report
613 Followers
NRIX Q2 2021 EPS Results
- Actual EPS
- -$0.60
- Consensus EPS
- -$0.54
- Beat/Miss
- Missed by -$0.06
- One Year Ago EPS
- $0.47
NRIX Q2 2021 Revenue Results
- Actual Revenue
- $7.09M
- Expected Revenue
- $8.23M
- Beat/Miss
- Missed by -$1.14M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/13/2021
- Time
- After Close
- Conference Call
- Tuesday, July 13, 2021
NRIX Upcoming Earnings
Nurix Therapeutics's next earnings date is estimated for February 17, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
NRIX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 17, 2027 | 2026 (Q4) | -0.41- | -0.82 | ― | ― |
| Oct 12, 2026 | 2026 (Q3) | -0.604.73 | -1.03 | 559.22% (+5.76) | |
| Jul 09, 2026 | 2026 (Q2) | -0.72-0.81 | -0.52 | -55.77% (-0.29) | |
| Apr 08, 2026 | 2026 (Q1) | -0.76-0.79 | -0.67 | -17.91% (-0.12) | |
| Jan 28, 2026 | 2025 (Q4) | -0.87-0.82 | -0.75 | -9.33% (-0.07) | |
| Oct 09, 2025 | 2025 (Q3) | -0.82-1.03 | -0.67 | -53.73% (-0.36) | |
| Jul 09, 2025 | 2025 (Q2) | -0.72-0.52 | -0.71 | 26.76% (+0.19) | |
| Apr 08, 2025 | 2025 (Q1) | -0.76-0.67 | -0.76 | 11.84% (+0.09) | |
| Jan 28, 2025 | 2024 (Q4) | -0.69-0.75 | -0.77 | 2.60% (+0.02) | |
| Oct 11, 2024 | 2024 (Q3) | -0.69-0.67 | -0.68 | 1.47% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
